stachydrine has been researched along with Cardiomegaly in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, TT; Chen, HH; Dong, Z; Guo, W; Lu, R; Wei, HC; Xu, YW; Zhang, C; Zhao, P | 1 |
| Liu, Z; Sang, M; Wu, D; Wu, Q; Xu, Y; Zhao, L | 1 |
2 other study(ies) available for stachydrine and Cardiomegaly
| Article | Year |
|---|---|
Stachydrine Protects Against Pressure Overload-Induced Cardiac Hypertrophy by Suppressing Autophagy.
Topics: Angiotensin II; Animals; Autophagy; Cardiomegaly; Cell Line; Heart; Male; Membrane Glycoproteins; Microtubule-Associated Proteins; Myocardium; NADH, NADPH Oxidoreductases; NADPH Oxidase 2; NADPH Oxidases; Phosphorylation; Pressure; Proline; Protective Agents; Rats, Wistar; Reactive Oxygen Species | 2017 |
Stachydrine ameliorates isoproterenol-induced cardiac hypertrophy and fibrosis by suppressing inflammation and oxidative stress through inhibiting NF-κB and JAK/STAT signaling pathways in rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cardiomegaly; Cytokines; Isoproterenol; Janus Kinase 2; Male; NF-kappa B; Oxidative Stress; Proline; Rats, Sprague-Dawley; Signal Transduction; STAT3 Transcription Factor | 2017 |